160 related articles for article (PubMed ID: 36332647)
1. Essential medicines for childhood cancer in Europe: a pan-European, systematic analysis by SIOPE.
Otth M; Brack E; Kearns PR; Kozhaeva O; Ocokoljic M; Schoot RA; Vassal G;
Lancet Oncol; 2022 Dec; 23(12):1537-1546. PubMed ID: 36332647
[TBL] [Abstract][Full Text] [Related]
2. Access to essential anticancer medicines for children and adolescents in Europe.
Vassal G; Kozhaeva O; Griskjane S; Arnold F; Nysom K; Basset L; Kameric L; Kienesberger A; Kamal S; Cherny N; Bricalli G; Latino N; Kearns P
Ann Oncol; 2021 Apr; 32(4):560-568. PubMed ID: 33388384
[TBL] [Abstract][Full Text] [Related]
3. Recommendations for the organisation of care in paediatric radiation oncology across Europe: a SIOPE-ESTRO-PROS-CCI-Europe collaborative project in the framework of the JARC.
Janssens GO; Timmermann B; Laprie A; Mandeville H; Padovani L; Chargari C; Journy N; Kameric L; Kienesberger A; Brunhofer M; Kozhaeva O; Gasparotto C; Kearns P; Boterberg T; Lievens Y; Vassal G
Eur J Cancer; 2019 Jun; 114():47-54. PubMed ID: 31059973
[TBL] [Abstract][Full Text] [Related]
4. Market access to new anticancer medicines for children and adolescents with cancer in Europe.
Schoot RA; Otth MA; Frederix GWJ; Leufkens HGM; Vassal G
Eur J Cancer; 2022 Apr; 165():146-153. PubMed ID: 35235871
[TBL] [Abstract][Full Text] [Related]
5. Challenges for children and adolescents with cancer in Europe: the SIOP-Europe agenda.
Vassal G; Fitzgerald E; Schrappe M; Arnold F; Kowalczyk J; Walker D; Hjorth L; Riccardi R; Kienesberger A; Jones KP; Valsecchi MG; Janic D; Hasle H; Kearns P; Petrarulo G; Florindi F; Essiaf S; Ladenstein R
Pediatr Blood Cancer; 2014 Sep; 61(9):1551-7. PubMed ID: 24706509
[TBL] [Abstract][Full Text] [Related]
6. Adolescents and young adults (AYA) with cancer: a position paper from the AYA Working Group of the European Society for Medical Oncology (ESMO) and the European Society for Paediatric Oncology (SIOPE).
Ferrari A; Stark D; Peccatori FA; Fern L; Laurence V; Gaspar N; Bozovic-Spasojevic I; Smith O; De Munter J; Derwich K; Hjorth L; van der Graaf WTA; Soanes L; Jezdic S; Blondeel A; Bielack S; Douillard JY; Mountzios G; Saloustros E
ESMO Open; 2021 Apr; 6(2):100096. PubMed ID: 33926710
[TBL] [Abstract][Full Text] [Related]
7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy and Supportive Care Agents as Essential Medicines for Children With Cancer.
Unguru Y; Bernhardt MB; Berg SL; Johnson LM; Pyke-Grimm K; Woodman C; Fernandez CV
JAMA Pediatr; 2019 May; 173(5):477-484. PubMed ID: 30830204
[TBL] [Abstract][Full Text] [Related]
9. Availability of cytotoxic medicines in the WHO essential medicine list used in treating childhood malignancies in low-income and lower-middle-income countries: a systematic review protocol.
Seneviwickrama M; Gunasekera S; Liyanage G; Heiyanthuduwa W; Jayakody S
BMJ Open; 2023 Jun; 13(6):e071988. PubMed ID: 37336532
[TBL] [Abstract][Full Text] [Related]
10. Defining Essential Childhood Cancer Medicines to Inform Prioritization and Access: Results From an International, Cross-Sectional Survey.
Denburg AE; Fundytus A; Khan MS; Howard SC; Antillon-Klussmann F; Sengar M; Lombe D; Hopman W; Jalink M; Gyawali B; Trapani D; Roitberg F; De Vries EGE; Moja L; Ilbawi A; Sullivan R; Booth CM
JCO Glob Oncol; 2022 Jun; 8():e2200034. PubMed ID: 35749676
[TBL] [Abstract][Full Text] [Related]
11. Evidence of clinical benefit of WHO essential anticancer medicines for children, 2011-2021.
Bai L; Zhan Y; Zhou Y; Zhang Y; Shi L; Gupta S; Denburg A; Guan X
EClinicalMedicine; 2023 May; 59():101966. PubMed ID: 37125406
[TBL] [Abstract][Full Text] [Related]
12. European Society for Paediatric Oncology (SIOPE) MRI guidelines for imaging patients with central nervous system tumours.
Avula S; Peet A; Morana G; Morgan P; Warmuth-Metz M; Jaspan T;
Childs Nerv Syst; 2021 Aug; 37(8):2497-2508. PubMed ID: 33973057
[TBL] [Abstract][Full Text] [Related]
13. Access to WHO Essential Medicines for Childhood Cancer Care in Trinidad and Tobago: A Health System Analysis of Barriers and Enablers.
Tang B; Bodkyn C; Gupta S; Denburg A
JCO Glob Oncol; 2020 Feb; 6():67-79. PubMed ID: 32031441
[TBL] [Abstract][Full Text] [Related]
14. Public health relevance of medicines developed under paediatric legislation in Europe and the USA: a systematic mapping study.
Volodina A; Jahn A; Jahn R
BMJ Paediatr Open; 2024 Apr; 8(1):. PubMed ID: 38569742
[TBL] [Abstract][Full Text] [Related]
15. Towards reducing inequalities: European Standards of Care for Children with Cancer.
Kowalczyk JR; Samardakiewicz M; Fitzgerald E; Essiaf S; Ladenstein R; Vassal G; Kienesberger A; Pritchard-Jones K
Eur J Cancer; 2014 Feb; 50(3):481-5. PubMed ID: 24300454
[TBL] [Abstract][Full Text] [Related]
16. Creating a unique, multi-stakeholder Paediatric Oncology Platform to improve drug development for children and adolescents with cancer.
Vassal G; Rousseau R; Blanc P; Moreno L; Bode G; Schwoch S; Schrappe M; Skolnik J; Bergman L; Bradley-Garelik MB; Saha V; Pearson A; Zwierzina H
Eur J Cancer; 2015 Jan; 51(2):218-24. PubMed ID: 25434924
[TBL] [Abstract][Full Text] [Related]
17. European Survey on Standards of Care in paediatric oncology centres.
Kowalczyk JR; Samardakiewicz M; Pritchard-Jones K; Ladenstein R; Essiaf S; Fitzgerald E; Petrarulo G; Vassal G
Eur J Cancer; 2016 Jul; 61():11-9. PubMed ID: 27131152
[TBL] [Abstract][Full Text] [Related]
18. Alignment in the registration, selection, procurement and reimbursement of essential medicines for childhood cancers in South Africa.
Joosse IR; van den Ham HA; Mantel-Teeuwisse AK; Suleman F
BMJ Glob Health; 2023 Sep; 8(9):. PubMed ID: 37730243
[TBL] [Abstract][Full Text] [Related]
19. What are the volume and budget needs to provide chemotherapy to all children with acute lymphoblastic leukaemia in Thailand? Development and application of an estimation tool.
Sruamsiri R; Ferrario A; Ross-Degnan D; Denburg AE; Frazier AL; Gupta S; Ward ZJ; Yeh JM; Wagner AK
BMJ Open; 2020 Oct; 10(10):e041901. PubMed ID: 33109678
[TBL] [Abstract][Full Text] [Related]
20. QUARTET: A SIOP Europe project for quality and excellence in radiotherapy and imaging for children and adolescents with cancer.
Kelly SM; Effeney R; Gaze MN; Bernier-Chastagner V; Blondeel A; Clementel E; Corning C; Dieckmann K; Essiaf S; Gandola L; Janssens GO; Kearns PR; Lacombe D; Lassen-Ramshad Y; Merks H; Miles E; Padovani L; Scarzello G; Schwarz R; Timmermann B; van Rijn RR; Vassal G; Boterberg T; Mandeville HC;
Eur J Cancer; 2022 Sep; 172():209-220. PubMed ID: 35780527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
